Drug-driven HRD: From Bench to Bedside & Back: Discovering Novel Biomarkers for PARP
Time: 9:30 am
day: Day Two
Details:
- Understanding and utilizing drug-driven Homologous Recombination Deficiency (HRD)
- Potentials and hope for a Rad51 biomarker
- Furthering the understanding of primary and acquired resistance to PARP inhibitors
